Key indicators: single-crystal X-ray study; T = 100 K; mean (C-C) = 0.008 Å; R factor = 0.052; wR factor = 0.121; data-to-parameter ratio = 13.4.
In the title compound, C 11 H 9 BrN 2 O, the molecules are linked into R 2 2 (8) dimers by paired N-HÁ Á ÁO hydrogen bonds and these dimers are further stacked into columns along the c axis byinteractions between pyrazinone rings [centroidcentroid distance = 3.544 Å ; the dihedral angle between the planes of these rings is 7. 51 (16) ]. The title compound is a precursor for agents with potential use as pharmaceuticals.
Related literature
For related literature, see: Betancur et al. (1997) ; Harrison et al. (1994) ; Rombouts et al. (2001 Rombouts et al. ( , 2003 ; Snider et al. (1991) .
Experimental
Crystal data C 11 H 9 BrN 2 O M r = 265.11 Orthorhombic, Pccn a = 12.0408 (16) Å b = 24.273 (3) Å c = 7.0428 (10) Å V = 2058.4 (5) Å 3 Z = 8 Mo K radiation = 3.97 mm À1 T = 100 (2) K 0.28 Â 0.16 Â 0.14 mm
Data collection
Bruker APEX CCD area-detector diffractometer Absorption correction: multi-scan (SADABS; Sheldrick, 1997) T min = 0.383, T max = 0.576 9901 measured reflections 1825 independent reflections 1242 reflections with I > 2(I) R int = 0.097 Refinement R[F 2 > 2(F 2 )] = 0.051 wR(F 2 ) = 0.120 S = 0.99 1825 reflections 136 parameters H-atom parameters constrained Á max = 0.71 e Å À3 Á min = À0.55 e Å À3 Table 1 Hydrogen-bond geometry (Å , ).
Symmetry code: (i) Àx þ 3 2 ; Ày þ 3 2 ; z.
Data collection: SMART (Bruker, 2001) ; cell refinement: SAINT (Bruker, 2002) ; data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008) ; program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: X-SEED (Barbour, 2001; Atwood & Barbour, 2003) ; software used to prepare material for publication: X-SEED;.
3-Benzyl-5-bromopyrazin-2(1H)-one J. Alen and L. Dobrzanska Comment During the early nineties Pfizer (Snider et al., 1991) and Merck (Harrison et al., 1994) optimized a type of compounds (Betancur et al., 1997) that may be of therapeutic use in the treatment of chronic pain, inflammation, depression, emesis, and asthma. (I) can be converted into similar agents with potential biological activity (Rombouts et al., 2001; Rombouts et al., 2003) . The molecular structure is given in Fig. 1 . The dihedral angle between the planes of the benzene ring (C10-C15) and the pyrazinone ring (C1-N6) is 67.1 (2)°. The r.m.s deviation from the mean plane for the C10-C15 benzene ring is 0.004 Å [maximum deviation = 0.007 (4) Å for atom C13]. For the pyrazinone ring the corresponding value is 0.009 Å [maximum deviation = 0.015 (4) Å for atom C5]. In the crystal packing around a twofold axes hydrogen-bonded dimers are formed through N3-H···O8 i hydrogen bond [symmetry code: (i) 3/2 − x, 3/2 − y, z; distance of 2.760 (5) Å (Table 1, Fig. 2 ). These dimers are stacked into columns by π-π interactions between pyrazinone rings along the c axis [centroid···centroid distances = 3.544 Å; symmetry codes: (ii) 3/2 − x, y, 1/2 + z and (iii) 3/2 − x, y, −1/2 + z] (Fig. 3 ). There are no direction-specific interactions between stacked columns ( Fig. 4) . Refinement. Refinement of F 2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F 2 , conventional R-factors R are based on F, with F set to zero for negative F 2 . The threshold expression of F 2 > 2sigma(F 2 ) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F 2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å 2 ) 
Geometric parameters (Å, °)
C1-C2 1.334 (7) C9-H9B 0.9900 C1-N6 1.347 (7) C10-C11 1.375 (7) 
